Go Deep
Neogen Chemicals Limited
Neogen Chemicals Limited Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 16,458 | 182.8 | 8.94 | 1.71 | 2,429.20 |
| Oct 2026 | 16,244 | 178.9 | 8.75 | 1.71 | 2,378.20 |
Neogen Chemicals Limited Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 2,502,900,000.0 | 2,465,600,000.0 | 2,200,200,000.0 | 2,086,600,000.0 |
| Net Profit | 171,100,000.0 | 113,900,000.0 | 36,900,000.0 | 33,700,000.0 |
| EPS | 6.3 | 4.3 | 1.4 | 1.3 |
Neogen Chemicals Limited Revenue & Profit: Last 5 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Revenue | 8,483,400,000.0 | 7,559,400,000.0 | 6,708,300,000.0 | 6,604,800,000.0 | — |
| Net Profit | 287,500,000.0 | 348,300,000.0 | 356,500,000.0 | 499,700,000.0 | — |
| EPS | 10.9 | 13.2 | 14.0 | 20.0 | — |
Neogen Chemicals Limited Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 29,018,700,000.0 | 17,473,100,000.0 | 14,614,000,000.0 | 10,538,000,000.0 | — |
| Total Liabilities | 20,856,000,000.0 | 9,579,100,000.0 | 7,011,100,000.0 | 5,712,800,000.0 | — |
| Total Equity | 8,162,700,000.0 | 7,894,000,000.0 | 7,602,900,000.0 | 4,825,200,000.0 | — |
Owes vs Owns
Neogen Chemicals Limited owed ₹0.72 for every ₹1 it owned in Mar 2026, up from ₹0.54 in Mar 2023.
| Period | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Owes vs Owns | 0.72× | 0.55× | 0.48× | 0.54× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Neogen Chemicals Limited Assets & Liabilities Breakdown (₹ Cr)
What it owns — Mar 2026
Receivables 13.1%Inventory 19.6%Fixed assets (tangible) 50.6%Other assets 16.5%
How it's funded — Mar 2026
Short-term debt 17.6%Long-term debt 28.2%Payables 15.7%Other liabilities 10.4%Shareholders' equity 28.1%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 4.9 | 5.0 | 15.3 | 96.8 |
| Receivables | 380.4 | 200.2 | 281.7 | 177.4 |
| Inventory | 568.2 | 309.1 | 382.4 | 293.0 |
| Fixed assets (tangible) | 1,469.2 | 725.6 | 662.1 | 385.6 |
| Intangible assets | 0.6 | 0.9 | 1.1 | 1.4 |
| Long-term investments | 0.5 | 0.5 | 0.5 | 0.8 |
| Other assets | 478.1 | 506.0 | 118.3 | 98.9 |
| Liabilities & equity | ||||
| Short-term debt | 510.7 | 395.9 | 269.3 | 233.1 |
| Long-term debt | 819.1 | 170.1 | 124.2 | 129.1 |
| Payables | 455.0 | 263.2 | 144.6 | 156.6 |
| Other liabilities | 300.7 | 128.7 | 163.0 | 52.5 |
| Shareholders' equity | 816.3 | 789.4 | 760.3 | 482.5 |
| Net tangible assets | 815.6 | 788.5 | 759.1 | 481.1 |
Neogen Chemicals Limited Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | -2,314,800,000.0 | 1,959,800,000.0 | -291,500,000.0 | -303,500,000.0 | — |
| Investing Activities | -4,102,600,000.0 | -3,165,900,000.0 | -2,155,800,000.0 | -944,600,000.0 | — |
| Financing Activities | 6,417,100,000.0 | 1,130,700,000.0 | 2,365,300,000.0 | 1,002,900,000.0 | — |